Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Role of magnetic resonance in the detection of cardiac involvement in patients with newly diagnosed extracardiac sarcoidosis: Single center experience

K. Kysperska, P. Kuchynka, A. Slovakova, L. Roblova, S. Havranek, Z. Fingrova, J. Habasko, M. Masek, L. Lambert, L. Navratova, T. Palecek

. 2022 ; 80 (9) : 897-901. [pub] 20220701

Jazyk angličtina Země Polsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc22033382

BACKGROUND: Sarcoidosis is a systemic inflammatory disease of unknown etiology, which can affect almost any organ. Cardiac involvement determines the prognosis of the affected individuals. Its prevalence in patients with extracardiac sarcoidosis with the absence of cardiac symptoms remains unclear. Cardiac magnetic resonance (CMR) provides excellent diagnostic accuracy in the detection of heart involvement by sarcoidosis. AIM: We sought to determine the prevalence of cardiac sarcoidosis in asymptomatic individuals with newly diagnosed extracardiac sarcoidosis using CMR. METHODS: We prospectively evaluated 55 consecutive patients including 23 women with newly diagnosed extracardiac sarcoidosis who underwent contrast-enhanced CMR and had no symptoms of heart disease. The mean (standard deviation) age of patients was 43 (11) years. The presence of myocardial late gadolinium enhancement (LGE) of non-ischemic etiology on CMR examination was considered diagnostic for cardiac sarcoidosis. RESULTS: In 3 (6%) patients, the LGE pattern consistent with cardiac sarcoidosis was detected. In all patients, preserved left ventricular systolic regional and global function was present, and in none of them, the elevation of blood biomarkers of myocardial injury or overload was found. CONCLUSIONS: Our study suggests that the prevalence of cardiac involvement in patients with newly diagnosed extracardiac sarcoidosis and no symptoms of heart disease is very low as assessed by CMR. However, CMR may be considered as part of routine evaluation of patients with extracardiac sarcoidosis due to its higher diagnostic yield in comparison with echocardiography and electrocardiography, respectively.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22033382
003      
CZ-PrNML
005      
20230131151624.0
007      
ta
008      
230120s2022 pl f 000 0|eng||
009      
AR
024    7_
$a 10.33963/KP.a2022.0163 $2 doi
035    __
$a (PubMed)35775447
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a pl
100    1_
$a Kysperska, Kristyna $u 2nd Department of Medicine, Department of Cardiovascular Medicine, 1st Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Prague, Czech Republic
245    10
$a Role of magnetic resonance in the detection of cardiac involvement in patients with newly diagnosed extracardiac sarcoidosis: Single center experience / $c K. Kysperska, P. Kuchynka, A. Slovakova, L. Roblova, S. Havranek, Z. Fingrova, J. Habasko, M. Masek, L. Lambert, L. Navratova, T. Palecek
520    9_
$a BACKGROUND: Sarcoidosis is a systemic inflammatory disease of unknown etiology, which can affect almost any organ. Cardiac involvement determines the prognosis of the affected individuals. Its prevalence in patients with extracardiac sarcoidosis with the absence of cardiac symptoms remains unclear. Cardiac magnetic resonance (CMR) provides excellent diagnostic accuracy in the detection of heart involvement by sarcoidosis. AIM: We sought to determine the prevalence of cardiac sarcoidosis in asymptomatic individuals with newly diagnosed extracardiac sarcoidosis using CMR. METHODS: We prospectively evaluated 55 consecutive patients including 23 women with newly diagnosed extracardiac sarcoidosis who underwent contrast-enhanced CMR and had no symptoms of heart disease. The mean (standard deviation) age of patients was 43 (11) years. The presence of myocardial late gadolinium enhancement (LGE) of non-ischemic etiology on CMR examination was considered diagnostic for cardiac sarcoidosis. RESULTS: In 3 (6%) patients, the LGE pattern consistent with cardiac sarcoidosis was detected. In all patients, preserved left ventricular systolic regional and global function was present, and in none of them, the elevation of blood biomarkers of myocardial injury or overload was found. CONCLUSIONS: Our study suggests that the prevalence of cardiac involvement in patients with newly diagnosed extracardiac sarcoidosis and no symptoms of heart disease is very low as assessed by CMR. However, CMR may be considered as part of routine evaluation of patients with extracardiac sarcoidosis due to its higher diagnostic yield in comparison with echocardiography and electrocardiography, respectively.
650    _2
$a dospělí $7 D000328
650    12
$a kardiomyopatie $x diagnostické zobrazování $7 D009202
650    _2
$a kontrastní látky $7 D003287
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a gadolinium $7 D005682
650    12
$a nemoci srdce $7 D006331
650    _2
$a lidé $7 D006801
650    _2
$a magnetická rezonanční tomografie $7 D008279
650    _2
$a magnetická rezonanční spektroskopie $7 D009682
650    12
$a sarkoidóza $x diagnóza $x diagnostické zobrazování $7 D012507
655    _2
$a časopisecké články $7 D016428
700    1_
$a Kuchynka, Petr $u 2nd Department of Medicine, Department of Cardiovascular Medicine, 1st Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Prague, Czech Republic. petr.kuchynka@vfn.cz
700    1_
$a Slovakova, Alena $u 1st Department of Tuberculosis and Respiratory Diseases, 1st Faculty of Medicine and General University Hospital in Prague, Prague, Czech Republic
700    1_
$a Roblova, Lenka $u 2nd Department of Medicine, Department of Cardiovascular Medicine, 1st Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Prague, Czech Republic
700    1_
$a Havranek, Stepan $u 2nd Department of Medicine, Department of Cardiovascular Medicine, 1st Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Prague, Czech Republic
700    1_
$a Fingrova, Zdenka $u 2nd Department of Medicine, Department of Cardiovascular Medicine, 1st Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Prague, Czech Republic
700    1_
$a Habasko, Jan $u 2nd Department of Medicine, Department of Cardiovascular Medicine, 1st Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Prague, Czech Republic
700    1_
$a Masek, Martin $u Department of Radiology, 1st Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic
700    1_
$a Lambert, Lukas $u Department of Radiology, 1st Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic
700    1_
$a Navratova, Lenka $u 1st Department of Tuberculosis and Respiratory Diseases, 1st Faculty of Medicine and General University Hospital in Prague, Prague, Czech Republic
700    1_
$a Palecek, Tomas $u 2nd Department of Medicine, Department of Cardiovascular Medicine, 1st Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Prague, Czech Republic
773    0_
$w MED00003056 $t Kardiologia polska $x 1897-4279 $g Roč. 80, č. 9 (2022), s. 897-901
856    41
$u https://pubmed.ncbi.nlm.nih.gov/35775447 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230120 $b ABA008
991    __
$a 20230131151620 $b ABA008
999    __
$a ok $b bmc $g 1891909 $s 1184717
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2022 $b 80 $c 9 $d 897-901 $e 20220701 $i 1897-4279 $m Kardiologia Polska $n Kardiol Pol $x MED00003056
LZP    __
$a Pubmed-20230120

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...